Beijing, China

Shen Chen

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shen Chen - Innovator in Photodynamic Therapy

Introduction

Shen Chen is a prominent inventor based in Beijing, China. He has made significant contributions to the field of photodynamic therapy through his innovative research and patents. His work focuses on developing novel compounds that enhance the effectiveness of treatments for serious health conditions.

Latest Patents

Shen Chen holds a patent for "Aliphatic amino-substituted demethoxylated hypocrellins and their synthesis." This invention involves methods and compositions for use in photodynamic therapy. The patent discloses novel perylenequinone derivatives, conjugates comprising these derivatives and a binding agent, as well as methods of treatment using these compositions. The present invention relates to photosensitizers that possess photodynamic activities. These compounds exhibit high photodynamic activities and low dark toxicities, making them more potent photodynamic agents than HPD against cancer and the AIDS virus. He has 1 patent to his name.

Career Highlights

Throughout his career, Shen Chen has worked with notable organizations, including Altachem Pharma Ltd. and the Institute of Photographic Chemistry Academia Sinica. His experience in these institutions has allowed him to advance his research and contribute to the development of effective therapeutic agents.

Collaborations

Shen Chen has collaborated with several professionals in his field, including Manhua Zhang and Shangjie Xu. These collaborations have enriched his research and expanded the impact of his innovations.

Conclusion

Shen Chen is a key figure in the advancement of photodynamic therapy, with a focus on developing effective treatments for cancer and viral infections. His innovative work continues to influence the field and offers hope for improved therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…